This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doern, G. V.
Right arrow Articles by Rauch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doern, G. V.
Right arrow Articles by Rauch, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Dec 1996, 2884-2886, Vol 40, No. 12
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study

GV Doern, AB Brueggemann, G Pierce, T Hogan, HP Holley Jr and A Rauch
Clinical Microbiology Laboratories, University of Massachusetts, Worcester 01655, USA.

Seven hundred twenty-three isolates of Moraxella catarrhalis obtained from outpatients with a variety of infections in 30 medical centers in the United States between 1 November 1994 and 30 April 1995 were characterized in a central laboratory. The overall rate of beta- lactamase production was 95.3%. When the National Committee for Clinical Laboratory Standards MIC interpretive breakpoints for Haemophilus influenzae were applied, percentages of strains found to be susceptible to selected oral antimicrobial agents were as follows: azithromycin, clarithromycin, and erythromycin, 100%; tetracycline and chloramphenicol, 100%; amoxicillin-clavulanate, 100%; cefixime, 99.3%; cefpodoxime, 99.0%; cefaclor, 99.4%; loracarbef, 99.0%; cefuroxime, 98.5%; cefprozil, 94.3%; and trimethoprim-sulfamethoxazole, 93.5%.


This article has been cited by other articles:

  • Liu, D.-F., McMichael, J. C., Baker, S. M. (2007). Moraxella catarrhalis Outer Membrane Protein CD Elicits Antibodies That Inhibit CD Binding to Human Mucin and Enhance Pulmonary Clearance of M. catarrhalis in a Mouse Model. Infect. Immun. 75: 2818-2825 [Abstract] [Full Text]  
  • Nilius, A. M., Shen, L. L., Hensey-Rudloff, D., Almer, L. S., Beyer, J. M., Balli, D. J., Cai, Y., Flamm, R. K. (2003). In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone. Antimicrob. Agents Chemother. 47: 3260-3269 [Abstract] [Full Text]  
  • Karlowsky, J. A., Thornsberry, C., Critchley, I. A., Jones, M. E., Evangelista, A. T., Noel, G. J., Sahm, D. F. (2003). Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States. Antimicrob. Agents Chemother. 47: 1790-1797 [Abstract] [Full Text]  
  • Zhanel, G. G., Palatnick, L., Nichol, K. A., Low, D. E., The CROSS Study Group,, , Hoban, D. J. (2003). Antimicrobial Resistance in Haemophilus influenzae and Moraxella catarrhalis Respiratory Tract Isolates: Results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob. Agents Chemother. 47: 1875-1881 [Abstract] [Full Text]  
  • Schmitz, F.-J., Beeck, A., Perdikouli, M., Boos, M., Mayer, S., Scheuring, S., Kohrer, K., Verhoef, J., Fluit, A. C. (2002). Production of BRO {beta}-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates. J. Clin. Microbiol. 40: 1546-1548 [Abstract] [Full Text]  
  • Verduin, C. M., Hol, C., Fleer, A., van Dijk, H., van Belkum, A. (2002). Moraxella catarrhalis: from Emerging to Established Pathogen. Clin. Microbiol. Rev. 15: 125-144 [Abstract] [Full Text]  
  • Wilson, R. (2001). Bacteria, antibiotics and COPD. Eur Respir J 17: 995-1007 [Abstract] [Full Text]  
  • Tubau, F., Fernandez-Roblas, R., Linares, J., Martin, R., Soriano, F. (2001). In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods. J Antimicrob Chemother 47: 675-680 [Abstract] [Full Text]  
  • Hu, W.-G., Chen, J., Battey, J. F., Gu, X.-X. (2000). Enhancement of Clearance of Bacteria from Murine Lungs by Immunization with Detoxified Lipooligosaccharide from Moraxella catarrhalis Conjugated to Proteins. Infect. Immun. 68: 4980-4985 [Abstract] [Full Text]  
  • Zhanel, G. G., Karlowsky, J. A., Low, D. E., Canadian Respiratory Infection Study Group, t., Hoban, D. J. (2000). Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998. J Antimicrob Chemother 45: 655-662 [Abstract] [Full Text]  
  • Adams, S. G., Melo, J., Luther, M., Anzueto, A. (2000). Antibiotics Are Associated With Lower Relapse Rates in Outpatients With Acute Exacerbations of COPD. Chest 117: 1345-1352 [Abstract] [Full Text]  
  • Dewan, N. A., Rafique, S., Kanwar, B., Satpathy, H., Ryschon, K., Tillotson, G. S., Niederman, M. S. (2000). Acute Exacerbation of COPD: Factors Associated With Poor Treatment Outcome. Chest 117: 662-671 [Abstract] [Full Text]  
  • Richter, S. S., Winokur, P. L., Brueggemann, A. B., Huynh, H. K., Rhomberg, P. R., Wingert, E. M., Doern, G. V. (2000). Molecular Characterization of the beta -Lactamases from Clinical Isolates of Moraxella (Branhamella) catarrhalis Obtained from 24 U.S. Medical Centers during 1994-1995 and 1997-1998. Antimicrob. Agents Chemother. 44: 444-446 [Abstract] [Full Text]  
  • Walker, E. S., Neal, C. L., Laffan, E., Kalbfleisch, J. H., Berk, S. L., Levy, F. (2000). Long-term trends in susceptibility of Moraxella catarrhalis: a population analysis. J Antimicrob Chemother 45: 175-182 [Abstract] [Full Text]  
  • Felmingham, D., Gruneberg, R. N., Alexander Project Group, T. (2000). The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 45: 191-203 [Abstract] [Full Text]  
  • Thornsberry, C., Jones, M. E., Hickey, M. L., Mauriz, Y., Kahn, J., Sahm, D. F. (1999). Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J Antimicrob Chemother 44: 749-759 [Abstract] [Full Text]  
  • Thornsberry, C., Ogilvie, P. T., Holley, H. P. Jr., Sahm, D. F. (1999). Survey of Susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study. Antimicrob. Agents Chemother. 43: 2612-2623 [Abstract] [Full Text]  
  • Bootsma, H. J., Aerts, P. C., Posthuma, G., Harmsen, T., Verhoef, J., van Dijk, H., Mooi, F. R. (1999). Moraxella (Branhamella) catarrhalis BRO beta -Lactamase: a Lipoprotein of Gram-Positive Origin?. J. Bacteriol. 181: 5090-5093 [Abstract] [Full Text]  
  • Doern, G. V., Jones, R. N., Pfaller, M. A., Kugler, K., The Sentry Participants Group, (1999). Haemophilus influenzae and Moraxella catarrhalis from Patients with Community-Acquired Respiratory Tract Infections: Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 43: 385-389 [Abstract] [Full Text]  
  • Block, S. L. (1999). Strategies for Dealing With Amoxicillin Failure in Acute Otitis Media. Arch Fam Med 8: 68-78 [Abstract] [Full Text]  
  • Myers, L. E., Yang, Y.-p., Du, R.-p., Wang, Q., Harkness, R. E., Schryvers, A. B., Klein, M. H., Loosmore, S. M. (1998). The Transferrin Binding Protein B of Moraxella catarrhalis Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen. Infect. Immun. 66: 4183-4192 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»